each of the directors of the Company (Michael G. Raab, Bradley L. Campbell, Lynn D. Bleil, Michael A. Kelly, Margaret G. McGlynn, Eiry W. Roberts, M.D., Glenn P. Sblendorio, Craig A. Wheeler and Burke W. Whitman) resigned and ceased to be directors of the Company and members of any committee of the Company’s board of directors.
Departed
Eiry W. Roberts
Director
AMICUS THERAPEUTICS, INC.
Effective
2026-04-27
Successor
Eric Davis, Brian Mueller
Filed
Apr 27, 2026 23:59 UTC
each of the directors of the Company (Michael G. Raab, Bradley L. Campbell, Lynn D. Bleil, Michael A. Kelly, Margaret G. McGlynn, Eiry W. Roberts, M.D., Glenn P. Sblendorio, Craig A. Wheeler and Burke W. Whitman) resigned and ceased to be directors of the Company and members of any committee of the Company’s board of directors.
Appointed
Brian Mueller
Director
AMICUS THERAPEUTICS, INC.
Effective
2026-04-27
Filed
Apr 27, 2026 23:59 UTC
The directors of Merger Sub immediately prior to the Effective Time were Eric Davis and Brian Mueller.
Departed
Ellen S. Rosenberg
Other Named Officer
AMICUS THERAPEUTICS, INC.
Effective
2026-04-27
Successor
Eric Davis (President and Secretary), Brian Mueller (Treasurer)
Filed
Apr 27, 2026 23:59 UTC
all executive officers of the Company immediately prior to the Effective Time (Bradley L. Campbell, Simon Harford, Ellen S. Rosenberg, David M. Clark and Jeffrey P. Castelli) ceased to be executive officers of the Surviving Corporation.
Departed
Burke W. Whitman
Director
AMICUS THERAPEUTICS, INC.
Effective
2026-04-27
Successor
Eric Davis, Brian Mueller
Filed
Apr 27, 2026 23:59 UTC
each of the directors of the Company (Michael G. Raab, Bradley L. Campbell, Lynn D. Bleil, Michael A. Kelly, Margaret G. McGlynn, Eiry W. Roberts, M.D., Glenn P. Sblendorio, Craig A. Wheeler and Burke W. Whitman) resigned and ceased to be directors of the Company and members of any committee of the Company’s board of directors.
Appointed
Eric Davis
President and Secretary
AMICUS THERAPEUTICS, INC.
Effective
2026-04-27
Filed
Apr 27, 2026 23:59 UTC
Eric Davis, as President and Secretary of Merger Sub immediately prior to the Effective Time, became President and Secretary of the Surviving Corporation
Departed
Simon Harford
Other Named Officer
AMICUS THERAPEUTICS, INC.
Effective
2026-04-27
Successor
Eric Davis (President and Secretary), Brian Mueller (Treasurer)
Filed
Apr 27, 2026 23:59 UTC
all executive officers of the Company immediately prior to the Effective Time (Bradley L. Campbell, Simon Harford, Ellen S. Rosenberg, David M. Clark and Jeffrey P. Castelli) ceased to be executive officers of the Surviving Corporation.
Departed
Michael A. Kelly
Director
AMICUS THERAPEUTICS, INC.
Effective
2026-04-27
Successor
Eric Davis, Brian Mueller
Filed
Apr 27, 2026 23:59 UTC
each of the directors of the Company (Michael G. Raab, Bradley L. Campbell, Lynn D. Bleil, Michael A. Kelly, Margaret G. McGlynn, Eiry W. Roberts, M.D., Glenn P. Sblendorio, Craig A. Wheeler and Burke W. Whitman) resigned and ceased to be directors of the Company and members of any committee of the Company’s board of directors.
Departed
Bradley L. Campbell
Director
AMICUS THERAPEUTICS, INC.
Effective
2026-04-27
Successor
Eric Davis, Brian Mueller
Filed
Apr 27, 2026 23:59 UTC
each of the directors of the Company (Michael G. Raab, Bradley L. Campbell, Lynn D. Bleil, Michael A. Kelly, Margaret G. McGlynn, Eiry W. Roberts, M.D., Glenn P. Sblendorio, Craig A. Wheeler and Burke W. Whitman) resigned and ceased to be directors of the Company and members of any committee of the Company’s board of directors.
Departed
Craig A. Wheeler
Director
AMICUS THERAPEUTICS, INC.
Effective
2026-04-27
Successor
Eric Davis, Brian Mueller
Filed
Apr 27, 2026 23:59 UTC
each of the directors of the Company (Michael G. Raab, Bradley L. Campbell, Lynn D. Bleil, Michael A. Kelly, Margaret G. McGlynn, Eiry W. Roberts, M.D., Glenn P. Sblendorio, Craig A. Wheeler and Burke W. Whitman) resigned and ceased to be directors of the Company and members of any committee of the Company’s board of directors.
Departed
Michael G. Raab
Director
AMICUS THERAPEUTICS, INC.
Effective
2026-04-27
Successor
Eric Davis, Brian Mueller
Filed
Apr 27, 2026 23:59 UTC
each of the directors of the Company (Michael G. Raab, Bradley L. Campbell, Lynn D. Bleil, Michael A. Kelly, Margaret G. McGlynn, Eiry W. Roberts, M.D., Glenn P. Sblendorio, Craig A. Wheeler and Burke W. Whitman) resigned and ceased to be directors of the Company and members of any committee of the Company’s board of directors.
Departed
Lynn D. Bleil
Director
AMICUS THERAPEUTICS, INC.
Effective
2026-04-27
Successor
Eric Davis, Brian Mueller
Filed
Apr 27, 2026 23:59 UTC
each of the directors of the Company (Michael G. Raab, Bradley L. Campbell, Lynn D. Bleil, Michael A. Kelly, Margaret G. McGlynn, Eiry W. Roberts, M.D., Glenn P. Sblendorio, Craig A. Wheeler and Burke W. Whitman) resigned and ceased to be directors of the Company and members of any committee of the Company’s board of directors.
Departed
Glenn P. Sblendorio
Director
AMICUS THERAPEUTICS, INC.
Effective
2026-04-27
Successor
Eric Davis, Brian Mueller
Filed
Apr 27, 2026 23:59 UTC
each of the directors of the Company (Michael G. Raab, Bradley L. Campbell, Lynn D. Bleil, Michael A. Kelly, Margaret G. McGlynn, Eiry W. Roberts, M.D., Glenn P. Sblendorio, Craig A. Wheeler and Burke W. Whitman) resigned and ceased to be directors of the Company and members of any committee of the Company’s board of directors.
Departed
Jeffrey P. Castelli
Other Named Officer
AMICUS THERAPEUTICS, INC.
Effective
2026-04-27
Successor
Eric Davis (President and Secretary), Brian Mueller (Treasurer)
Filed
Apr 27, 2026 23:59 UTC
all executive officers of the Company immediately prior to the Effective Time (Bradley L. Campbell, Simon Harford, Ellen S. Rosenberg, David M. Clark and Jeffrey P. Castelli) ceased to be executive officers of the Surviving Corporation.
Appointed
Eric Davis
Director
AMICUS THERAPEUTICS, INC.
Effective
2026-04-27
Filed
Apr 27, 2026 23:59 UTC
The directors of Merger Sub immediately prior to the Effective Time were Eric Davis and Brian Mueller.
Departed
David M. Clark
Other Named Officer
AMICUS THERAPEUTICS, INC.
Effective
2026-04-27
Successor
Eric Davis (President and Secretary), Brian Mueller (Treasurer)
Filed
Apr 27, 2026 23:59 UTC
all executive officers of the Company immediately prior to the Effective Time (Bradley L. Campbell, Simon Harford, Ellen S. Rosenberg, David M. Clark and Jeffrey P. Castelli) ceased to be executive officers of the Surviving Corporation.
Appointed
Brian Mueller
Treasurer
AMICUS THERAPEUTICS, INC.
Effective
2026-04-27
Filed
Apr 27, 2026 23:59 UTC
Brian Mueller, as Treasurer of Merger Sub immediately prior to the Effective Time, became Treasurer of the Surviving Corporation
Departed
Bradley L. Campbell
Other Named Officer
AMICUS THERAPEUTICS, INC.
Effective
2026-04-27
Successor
Eric Davis (President and Secretary), Brian Mueller (Treasurer)
Filed
Apr 27, 2026 23:59 UTC
all executive officers of the Company immediately prior to the Effective Time (Bradley L. Campbell, Simon Harford, Ellen S. Rosenberg, David M. Clark and Jeffrey P. Castelli) ceased to be executive officers of the Surviving Corporation.
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.